Analysis of the clinical characteristics in 18 patients with novel coronavirus pneumonia: Observational study Authors: Gao Chen, Chun-Jun Qin, Meng-Zheng Wu, Shu-Shu Liu, Li Liu, Jian-Ying Liu Published: 2023 ABSTRACT The aim of the present study was to analyze the clinical features, treatments, and short-term prognoses of 18 patients with novel coronavirus pneumonia (NCP) in order to provide reference for further clinical prevention and control of the epidemic. From January 29 to February 29, 2020, data from 18 patients with NCP who were positive for the 2019 novel coronavirus nucleic acid test were collected, and their clinical manifestations, laboratory tests, imaging features, and treatment protocols were analyzed retrospectively. From among the 18 patients with NCP, 9 (50%) were imported cases and 9 (50%) had contact histories with confirmed adult patients. Clinical classification was mainly of the normal type (16 cases, 88.9%). Fever and cough were common clinical symptoms, and the main laboratory indices were lymphocytopenia and leukocytopenia. The main imaging findings yielded ground-glass opacity in 12 cases (66.7%) and patchy opacity in 9 cases (50%). All 18 patients were treated with antiviral therapy and targeted treatment in accordance with their symptoms, returned negative nucleic acid tests (9–23 days) after their treatment, and were cured and discharged by March 5, 2020. During the early stages in Deyang, most patients with NCP were input cases; in the later stages, the main route of infection was close contact within the family. Close contact history in epidemiology, nucleic acid detection, and chest imaging were important references for diagnosis. Antiviral therapy resulted in good therapeutic effects. Adopting multi-departmental consultation and remote consultation in combination with traditional Chinese medicine treatment and psychological counseling may result in a good short-term prognosis. 1. Introduction In December 2019, the novel coronavirus pneumonia (NCP) was diagnosed in the city of Wuhan in the Hubei province[1] of the People Republic of China. Since then, the number of cases risen rapidly,[2] and the virus has subsequently spread around the entire globe, resulting in a pandemic[3,4] that has had a serious impact on the safety of people lives, societies, and economies worldwide. The virus was officially designated by the World Health Organization as the 2019 novel coronavirus (2019-nCoV) on February 1, 2020.[5,6] The 2019-nCoV is characterized by human transmission, rapid transmission, and strong pathogenicity.[7] According to the latest statistics from the National Health Commission of the People Republic of China—as of May 5, 2020—there are 339 current confirmed cases, 82,883 cumulative reported cases, 4633 cumulative deaths, and 77,911 cumulative discharged cases nationwide.[8] Deyang, Sichuan province, governs 2 districts and 1 county, and manages 3 county-level cities adjacent to Chengdu. Deyang People Hospital is the only designated medical unit in the area of Deyang to treat patients suffering from 2019-nCoV. From January 29 to February 29, 2020, 18 confirmed cases were admitted. After treatment, those 18 cases have been discharged. The clinical data of the 18 cases of NCP were retrospectively analyzed for the purposes of the present study. 2. Subjects and methods 2.1. Study subjects According to the diagnostic criteria outlined in the NCP Diagnosis and Treatment Plan (Trial Version 7), issued on March 3, 2020 by the National Health Commission of the People Republic of China,[7] the 18 patients with NCP admitted to Deyang People Hospital from January 29 to March 5, 2020 were enrolled in the present study. From among the 18 NCP patients, 10 were male (55.6%) and 8 were female (44.4%), with ages ranging from 1 month to 75 years. 2.2. Methods The epidemiological history, clinical manifestations, laboratory examinations, and imaging results of the 18 patients were collected, and their treatments and short-term prognoses were analyzed retrospectively. The study was conducted in accordance with the Declaration of Helsinki (as was revised in 2013). The study was approved by Ethics Committee of the People Hospital of Deyang City. Written informed consent was obtained from all participants. 3. Results 3.1. Epidemiological characteristics From among the 18 patients, 9 cases (50%) were imported and 9 (50%) were local. Nine (50%) patients had a contact history with confirmed adult patients (there was no definite contact history for the remaining cases). Sixteen patients (89%) belonged to cluster cases (11 family cluster and 5 public cluster case) (Table 1). Table 118 novel coronavirus pneumonia cases: age and origin.FeaturesFirst generation cases (n = 9)Second generation cases (n = 9)Total cases (n = 18)Age Median (interquartile interval)—yr—distribution—number/total number of cases47 (31–49)44 (43–66)44.5 (37.5–52) 0–14 yr1/91/92/18 15–49 yr6/95/911/18 50–64 yr1/901/18 >=65 yr old1/93/94/18Exposure history of infectious sources Living in Wuhan505 Living in Jingzhou303 I have been to Jingzhou recently101Contact with people returning from epidemic areas099 18 novel coronavirus pneumonia cases: age and origin. 3.2. Clinical manifestations Of the 18 patients, 2 were of the mild type (11.1%), 12 were normal (66.7%), and 4 were severe (22.2%). Their clinical symptoms were mainly fever and dry cough, which were consistent with the clinical characteristics described in most relevant literature.[9] Initial symptoms were as follows: fever in 6 cases (33%), cough in 4 cases (22%), diarrhea in 2 cases (11%), dizziness and headache in 2 cases (11%), stool change in 2 cases (11%), asthenia in 1 case (6%), and asymptomicity in 2 cases (11%) (Table 2). Table 218 novel coronavirus pneumonia: basic information and clinical features.FeaturesFirst generation cases (n = 9)Second generation cases (n = 9)Total cases (n = 18)Sex—number of females/total cases (%)4/94/98/18Median latency (interquartile interval)—d10.5 (4–12)8 (7–9)8 (4–12)First symptom: number of cases Fever246 Cough134 Nothing213 Diarrhea022 Headache and dizziness202 Stool changes112 Weakness101Main clinical manifestations: Cases Cough358 Weakness347 Fever347 Expectoration134 Dry cough123 Dizziness and headache303 The whole body aches.022 Diarrhea022 Tight breath112 Sore throat011 Loss of appetite011 Vomit milk011 Right chest pain011 18 novel coronavirus pneumonia: basic information and clinical features. 3.3. Laboratory tests Laboratory tests revealed that 17 cases (94.44%) were lymphocytopenia, 15 cases (83.33%) were leucocytopenic, 13 cases (72.22%) had elevated levels of C-reactive protein, and 11 cases (61.11%) had decreased levels of procalcitonin. Elevated ESR was found in 7 cases (38.89%), and 5 cases (27.78%) showed increased myoglobin levels. Increased levels of bilirubin were found in 4 cases (22.22%). The increase of alanine transaminase was found in 3 cases (16.67%), aspartate transaminase in 3 cases (16.67%) (Table 3). Table 3Laboratory findings of 18 novel coronavirus pneumonia cases.FeaturesFirst generation cases (n = 9)Second generation cases (n = 9)Total cases (n = 18)Laboratory examination data—number of cases Lymphopenia9817 Leukopenia9615 C-reactive protein increased8513 Procalcitonin elevation7411 Increased erythrocyte sedimentation rate527 Myoglobin elevation415 Hyperbilirubinemia314 ALT increased303 AST increased303 Laboratory findings of 18 novel coronavirus pneumonia cases. 3.4. Imaging Seventeen (94.4%) of the 18 patients manifested abnormal changes in their chest computed tomography (CT), and lesions were bilaterally ubiquitous in the lungs. Typical features can be summarized as follows: ground-glass opacity in 12 cases (66.7%); patch opacity in 9 cases (50%); increased, thickened, and disordered bilateral lung markings in 4 cases (22.2%); strip shadow in 3 cases (16.7%); nodular shadow in 1 case (5.6%); bilateral pleural thickening in 1 case (5.6%); interstitial changes in 1 case (5.6%); and pulmonary consolidation in 1 case (5.6%). From among the 18 patients, the chest CT manifestations in 16 (88.9%) were in accordance with the presence of viral pneumonia. One (5.6%) pediatric patient with NCP showed no abnormality in their chest CT. One (5.6%) patient showed a small spot shadow and a cord-like shadow in the medial segment of the middle lobe of their right lung with small nodule shadow scattering in the bilateral subpleural area—which were considered to be chronic inflammatory foci—and lymph nodes with pulmonary hyperplasia, a slight calcification in the bilateral lower lobes, and no typical CT signs of viral pneumonia (progress of chest CT in typical cases Fig. 1) (Table 4). Table 4Imaging examination of 18 novel coronavirus pneumonia cases.FeaturesFirst generation cases (n = 9)Second generation cases (n = 9)Total cases (n = 18)Imaging examination: number of cases Abnormal change9817 Ground glass opacity8412 Patchy shadow729 Bilateral lung markings increased, thickened and disordered314 Stripe shadow303 Nodular shadow101 Bilateral pleural thickening101 Interstitial changes101 Pulmonary consolidation101 Imaging examination of 18 novel coronavirus pneumonia cases. A 47 yr old female generation of patients from February 4, 2020 to March 3, 2020, 6 consecutive chest CT, the results showed that from the lung grinding glass lesions and gradually increased, and then gradually decreased, and progressive lung fiber, cord, spot lesions. CT = computed tomography. 3.5. Treatment and short-term prognosis After admission, all patients were isolated according to standards. The details of their diagnostic and therapeutic protocols jointly formulated via multi-departmental consultation and remote consultation were as follows. Antiviral therapy was adopted for all 18 patients. One pediatric patient (5 years and 8 months old) was treated with interferon aerosol inhalation and Abidol. One infant patient (1 month and 20 days old) was treated with interferon aerosol inhalation only. Thymosin was added to the treatments of 8 patients, antibiotics were used in 6 cases, chloroquine was used in 3 cases, and 12 cases made use of traditional Chinese medicine. Of the 4 severe cases, 3 were treated with oxygen inhalation, 2 with hormones, and 2 with antibiotics. Along with the aforementioned treatments, the patients’ psychological changes were monitored closely, and psychological counseling was conducted timely (Table 5). Table 5Statistics on treatment regimens for 18 cases of coronavirus infection.Treatment methodNumber of patients (n = 18)Number of critically ill patients (n = 4)Antiviral therapy184 Interferon + lopinavir ritonavir + ribavirin110 Interferon + lopinavir ritonavir tablet + Abidor + ribavirin22 Interferon + lopinavir ritonavir tablet + Abidor22 Interferon + Arbidol20 Interferon10Antibiotic therapy62Hormone therapy22Chloroquine therapy31Traditional Chinese Medicine123Transnasal high-flow oxygenation33Thymosin81 Statistics on treatment regimens for 18 cases of coronavirus infection. After treatment, changes in the 18 patients’ lung CTs were noted, and their respiratory and/or digestive symptoms were either vastly improved or disappeared entirely. All patients received negative results from the nucleic acid test. As of March 5, 2020, all 18 patients were cured and discharged; no deaths were reported. 4. Discussion The seventh member of the human coronavirus family to be discovered is 2019-nCoV; it possesses strong transmission characteristics, and the population is generally susceptible to it.[10] Common clinical manifestations in infected patients are fever, dry cough, and fatigue. In a few patients with severe symptoms (e.g., nasal obstruction, runny nose, pharyngeal pain, myalgia, and diarrhea), acute respiratory distress syndrome, multiple organ failure, and even death can result.[7] The area of Deyang belongs to a secondary epidemic area that had mainly imported cases at first that developed into local cases soon after. Family aggregation was the main transmission pathway. In the present study, patients’ early clinical manifestations were similar to those of influenza, namely fever and cough, and were consistent with reports from the main epidemic areas.[11–13] Chest CT findings included mainly ground-glass opacity and patchy opacity, which were consistent with previous reports.[14,15] However, pulmonary consolidation was rare, which may have been due to earlier treatments and interventions in the area. No specific findings were present in the early clinical manifestations or experimental examinations, but some studies suggested that the lack of an increase or a non-significant increase in leukocytes during the initial stages, together with a progressive decrease in lymphocytes, were regarded as indications of a poor prognosis.[16] Definite diagnosis still relies on an etiological examination by nucleic acid detection. Early and multiple nucleic acid tests should be carried out for suspected cases in clinical practice. Antiviral therapy utilizing a variety of drugs was adopted for all patients in the present study. Hormone therapy was added for 2 of the 4 patients with the severe type. However, further evidence is necessary to evaluate whether hormone therapy is of real benefit to patients. Remdesivir has been suggested for use in the treatment of 2019-nCoV,[17] but its efficacy and safety still need to be confirmed via multi-center clinical research. 5. Conclusion Currently, the domestic epidemic situation begun its conclusion, but vigilance should still be kept. For patients with fever, dry cough, fatigue, and other influenza-like symptoms—and patients with ground-glass opacity-like changes in lung CT—attention should be paid to investigation into epidemiological history, and etiological monitoring for suspected cases should be conducted as early and often as possible. Therapeutic protocols should refer to the NCP Diagnosis and Treatment Plan (Trial Version 7). Patients should be treated under multidisciplinary and remote consultation, and individualized therapeutic protocols should be formulated according to the given patient specific condition. The effects of combination treatment with Chinese medicine were good.[18] During treatment, patients often experienced anxiety and restlessness, becoming unwilling to cooperate. Attention should be paid to patients’ psychological situations during the entirety of the treatment process. If necessary, the Department of Physical and Mental Medicine should be consulted, and psychological counseling should be administered. Because the risk of patients spreading the disease after recovery and discharge remains, it is of great importance that 14 days of health monitoring and medical observation be performed after discharge. The 18 patients whose cases were the subject of the present study should be followed up with in the future. The number of cases in this study was small; studies with large samples are still needed in the future to provide data for the diagnosis and treatment of NCP. Acknowledgments We are particularly grateful to all the people who have given us help on our article. Author contributions Conceptualization: Gao Chen, Chun-Jun Qin. Data curation: Chun-Jun Qin, Li Liu. Formal analysis: Gao Chen, Meng-Zheng Wu. Investigation: Jian-Ying Liu. Methodology: Li Liu. Resources: Chun-Jun Qin. Supervision: Shu-Shu Liu. Validation: Meng-Zheng Wu. Writing – original draft: Gao Chen, Jian-Ying Liu. Writing – review & editing: Shu-Shu Liu.